Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...
[16] The reported incidence in the earlier literature varies from no neuropathy to over 90%. [1],4-8,20] This might be due to differences in patient selection or variation in the criteria used for ...
Neuropathy affects nearly 25 million Americans every day and the typical solution only masks the problem without getting to the root cause. Health From Within Chiropractic has a better ...
Neuropathy, a condition causing numbness, a prickling sensation, and discomfort in various body areas such as the hands and feet, impacts millions globally. While a confirmed cure for neuropathy ...